Shandong Wohua Pharmaceutical Co Ltd (002107) — Cash Flow Reinvestment Rate
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Cash Flow Reinvestment Rate of 0.03x as of June 2025, reinvesting CN¥820.27K (capex CN¥389.19K plus investments CN¥431.08K) from operating cash flow of CN¥27.12 Million. Check cash flow quality index of Shandong Wohua Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Wohua Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Shandong Wohua Pharmaceutical Co Ltd across 21 annual periods. Explore debt repayment capacity of Shandong Wohua Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Shandong Wohua Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002107 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | CN¥864.50K | CN¥128.53 Million | CN¥864.50K | ▼ -91.7% |
| 2024 | 0.08x | CN¥7.42 Million | CN¥91.51 Million | CN¥3.82 Million | ▲ +96.4% |
| 2023 | 0.04x | CN¥5.34 Million | CN¥129.25 Million | CN¥2.72 Million | ▼ -38.1% |
| 2022 | 0.07x | CN¥12.37 Million | CN¥185.26 Million | CN¥6.77 Million | ▼ -65.0% |
| 2021 | 0.19x | CN¥38.15 Million | CN¥200.12 Million | CN¥19.08 Million | ▼ -52.5% |
| 2020 | 0.40x | CN¥78.91 Million | CN¥196.58 Million | CN¥54.17 Million | ▼ -81.1% |
| 2019 | 2.13x | CN¥67.39 Million | CN¥31.66 Million | CN¥32.23 Million | ▲ +83.3% |
| 2018 | 1.16x | CN¥125.32 Million | CN¥107.88 Million | CN¥63.10 Million | ▲ +377.9% |
| 2017 | 0.24x | CN¥30.11 Million | CN¥123.88 Million | CN¥15.07 Million | ▼ -66.1% |
| 2016 | 0.72x | CN¥52.29 Million | CN¥72.91 Million | CN¥27.66 Million | ▲ +892.7% |
| 2015 | 0.07x | CN¥9.60 Million | CN¥132.82 Million | CN¥9.60 Million | ▼ -43.9% |
| 2014 | 0.13x | CN¥3.43 Million | CN¥26.58 Million | CN¥3.43 Million | ▼ -86.3% |
| 2013 | 0.94x | CN¥14.25 Million | CN¥15.15 Million | CN¥14.25 Million | ▲ +19.5% |
| 2012 | 0.79x | CN¥26.65 Million | CN¥33.86 Million | CN¥26.65 Million | ▼ -97.1% |
| 2011 | 27.05x | CN¥36.84 Million | CN¥1.36 Million | CN¥36.84 Million | ▲ +1731.1% |
| 2008 | 1.48x | CN¥52.58 Million | CN¥35.59 Million | CN¥52.58 Million | ▼ -71.7% |
| 2007 | 5.21x | CN¥54.52 Million | CN¥10.46 Million | CN¥54.52 Million | ▲ +262.1% |
| 2006 | 1.44x | CN¥66.32 Million | CN¥46.05 Million | CN¥66.32 Million | ▲ +92.2% |
| 2005 | 0.75x | CN¥9.75 Million | CN¥13.01 Million | CN¥9.75 Million | ▲ +3524.5% |
| 2004 | 0.02x | CN¥698.06K | CN¥33.77 Million | CN¥698.06K | ▼ -85.5% |
| 2003 | 0.14x | CN¥2.59 Million | CN¥18.17 Million | CN¥2.59 Million | — |